Poseida Therapeutics Inc (PSTX)
3.19
-0.16
(-4.63%)
USD |
NASDAQ |
May 17, 16:00
3.19
0.00 (0.00%)
After-Hours: 20:00
Poseida Therapeutics Cash from Operations (Quarterly): -15.14M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -15.14M |
| December 31, 2023 | -28.74M |
| September 30, 2023 | 7.888M |
| June 30, 2023 | -33.31M |
| March 31, 2023 | -38.00M |
| December 31, 2022 | 2.403M |
| September 30, 2022 | 61.88M |
| June 30, 2022 | -39.73M |
| March 31, 2022 | -51.32M |
| December 31, 2021 | 8.473M |
| September 30, 2021 | -40.87M |
| Date | Value |
|---|---|
| June 30, 2021 | -31.09M |
| March 31, 2021 | -39.06M |
| December 31, 2020 | -30.32M |
| September 30, 2020 | -29.33M |
| June 30, 2020 | -30.80M |
| March 31, 2020 | -22.88M |
| December 31, 2019 | -16.56M |
| September 30, 2019 | -19.17M |
| June 30, 2019 | -14.12M |
| March 31, 2019 | -14.66M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-51.32M
Minimum
Mar 2022
61.88M
Maximum
Sep 2022
-19.99M
Average
-29.04M
Median
Cash from Operations (Quarterly) Benchmarks
| Biomea Fusion Inc | -32.03M |
| Cartesian Therapeutics Inc | -15.92M |
| Lantern Pharma Inc | -3.068M |
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 24.00M |
| Cash from Financing (Quarterly) | -0.043M |
| Free Cash Flow | -71.71M |
| Free Cash Flow Per Share (Quarterly) | -0.159 |
| Free Cash Flow to Equity (Quarterly) | -15.37M |
| Free Cash Flow Yield | -24.27% |